Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

12.06

+0.20 (1.69%)

At close: Jul 14, 2025, 4:00 PM

11.59

-0.47 (-3.90%)

After-hours: Jul 14, 2025, 5:34 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Antisense Oligonucleotide	8.78M	Log In
Antisense Oligonucleotide Growth	-29.22%	Log In

Revenue by Geography

Fiscal year is January - December.